Advaxis Management Discusses FY2009 on Results Call.

Business WireMarch 01, 2010

Linked as:

Extract


Advaxis Management Discusses FY2009 on Results Call.

Highlights, Milestones and Future Growth Strategy

NORTH BRUNSWICK, N.J. -- Advaxis, Inc., (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, conducted its fiscal year end re...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company